Cargando…

Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats

BACKGROUND AND AIM: A neuronal pathway participates in the development of portal hypertension: blockade of afferent sensory nerves in portal vein ligated (PVL) rats simultaneously prevents brain cardiovascular regularory nuclei activation, neuromodulator overexpression in superior mesenteric ganglia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezkurdia, Nahia, Raurell, Imma, Rodríguez, Sarai, González, Antonio, Esteban, Rafael, Genescà, Joan, Martell, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882227/
https://www.ncbi.nlm.nih.gov/pubmed/24400086
http://dx.doi.org/10.1371/journal.pone.0084374
_version_ 1782298326903816192
author Ezkurdia, Nahia
Raurell, Imma
Rodríguez, Sarai
González, Antonio
Esteban, Rafael
Genescà, Joan
Martell, María
author_facet Ezkurdia, Nahia
Raurell, Imma
Rodríguez, Sarai
González, Antonio
Esteban, Rafael
Genescà, Joan
Martell, María
author_sort Ezkurdia, Nahia
collection PubMed
description BACKGROUND AND AIM: A neuronal pathway participates in the development of portal hypertension: blockade of afferent sensory nerves in portal vein ligated (PVL) rats simultaneously prevents brain cardiovascular regularory nuclei activation, neuromodulator overexpression in superior mesenteric ganglia, sympathetic atrophy of mesenteric innervation and hemodynamic alterations. Here we investigated in PVL rats alterations in neuromodulators and signaling pathways leading to axonal regression or apoptosis in the superior mesenteric ganglia and tested the effects of the stimulation of neuronal proliferation/survival by using a tyrosine kinase receptor A agonist, gambogic amide. RESULTS: The neuronal pathway was confirmed by an increased neuronal afferent activity at the vagal nodose ganglia and the presence of semaphorin3A in sympathetic pre-ganglionic neurons at the intermediolateral nucleus of the spinal cord of PVL rats. Expression of the active form of tyrosine kinase receptor A (phosphorylated), leading to proliferation and survival signaling, showed a significant reduction in PVL comparing to sham rats. In contrast, the apoptotic and axonal retraction pathways were stimulated in PVL, demonstrated by a significant overexpression of semaphorin 3A and its receptor neuropilin1, together with increases of cleaved caspase7, inactive poly(ADP-ribose) polymerase and Rho kinase expression. Finally, the administration of gambogic amide in PVL rats showed an amelioration of hemodynamic alterations and sympathetic atrophy, through the activation of survival pathways together with the inhibition of apoptotic cascades and Rho kinase mediated axonal regression. CONCLUSION: The adrenergic alteration and sympathetic atrophy in mesenteric vessels during portal hypertension is caused by alterations on neuromodulation leading to post-ganglionic sympathetic regression and apoptosis and contributing to splanchnic vasodilation.
format Online
Article
Text
id pubmed-3882227
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38822272014-01-07 Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats Ezkurdia, Nahia Raurell, Imma Rodríguez, Sarai González, Antonio Esteban, Rafael Genescà, Joan Martell, María PLoS One Research Article BACKGROUND AND AIM: A neuronal pathway participates in the development of portal hypertension: blockade of afferent sensory nerves in portal vein ligated (PVL) rats simultaneously prevents brain cardiovascular regularory nuclei activation, neuromodulator overexpression in superior mesenteric ganglia, sympathetic atrophy of mesenteric innervation and hemodynamic alterations. Here we investigated in PVL rats alterations in neuromodulators and signaling pathways leading to axonal regression or apoptosis in the superior mesenteric ganglia and tested the effects of the stimulation of neuronal proliferation/survival by using a tyrosine kinase receptor A agonist, gambogic amide. RESULTS: The neuronal pathway was confirmed by an increased neuronal afferent activity at the vagal nodose ganglia and the presence of semaphorin3A in sympathetic pre-ganglionic neurons at the intermediolateral nucleus of the spinal cord of PVL rats. Expression of the active form of tyrosine kinase receptor A (phosphorylated), leading to proliferation and survival signaling, showed a significant reduction in PVL comparing to sham rats. In contrast, the apoptotic and axonal retraction pathways were stimulated in PVL, demonstrated by a significant overexpression of semaphorin 3A and its receptor neuropilin1, together with increases of cleaved caspase7, inactive poly(ADP-ribose) polymerase and Rho kinase expression. Finally, the administration of gambogic amide in PVL rats showed an amelioration of hemodynamic alterations and sympathetic atrophy, through the activation of survival pathways together with the inhibition of apoptotic cascades and Rho kinase mediated axonal regression. CONCLUSION: The adrenergic alteration and sympathetic atrophy in mesenteric vessels during portal hypertension is caused by alterations on neuromodulation leading to post-ganglionic sympathetic regression and apoptosis and contributing to splanchnic vasodilation. Public Library of Science 2014-01-06 /pmc/articles/PMC3882227/ /pubmed/24400086 http://dx.doi.org/10.1371/journal.pone.0084374 Text en © 2014 Ezkurdia et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ezkurdia, Nahia
Raurell, Imma
Rodríguez, Sarai
González, Antonio
Esteban, Rafael
Genescà, Joan
Martell, María
Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
title Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
title_full Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
title_fullStr Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
title_full_unstemmed Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
title_short Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats
title_sort inhibition of neuronal apoptosis and axonal regression ameliorates sympathetic atrophy and hemodynamic alterations in portal hypertensive rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882227/
https://www.ncbi.nlm.nih.gov/pubmed/24400086
http://dx.doi.org/10.1371/journal.pone.0084374
work_keys_str_mv AT ezkurdianahia inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats
AT raurellimma inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats
AT rodriguezsarai inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats
AT gonzalezantonio inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats
AT estebanrafael inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats
AT genescajoan inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats
AT martellmaria inhibitionofneuronalapoptosisandaxonalregressionamelioratessympatheticatrophyandhemodynamicalterationsinportalhypertensiverats